Home | Contact Us | Site Map

News & Resources

Investor & Media Relations

Robert Bennett, Vice President of Investor Relations & Operations

investorrelations@biocryst.com

Resources

BioCryst designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. Learn more about our Company